Does Lactobacillus Reuteri affect Spirometry Parameters in Cystic Fibrosis patients? - Vienna 2024

Inflammation and new insights into cystic fibrosis

Chair(s): B?lent Taner Karadag, Oded Breuer

Session type: Oral presentation

Does Lactobacillus Reuteri affect Spirometry Parameters in Cystic Fibrosis patients?

Seyedeh Zalfa Modarresi

EVENTS HOME

Previous presentation

Next presentation

Session content

Neutrophil elastase and myeloperoxidase in airway extracellular vesicles of cystic fibrosis children during pulmonary exacerbations

Elad Ben-meir

Replay

Poster

Abstract

Slides

The role of periostin in cystic fibrosis and severity of disease in children with cystic fibrosis

Tu?ba ?i?manlar Eyuboglu

Replay

Poster

Abstract

Slides

Does the highly effective modulator therapy influence airway inflammation in people with cystic fibrosis?

Irena Wojsyk-banaszak

Replay

Poster

Abstract

Slides

Impact of the Lung Clearance Index on clinical decision-making in children with cystic fibrosis

Lucy Perrem

Replay

Poster

Abstract

Slides

Ventilation distribution efficiency or lung clearance index: Does it matter?

Christine Sachs Olsen

Replay

Poster

Abstract

Slides

Our new stethoscope LUS, with a new scoring system, in CF lung disease

Sule Selin Akyan Soyda?

Replay

Abstract

Slides

Does Lactobacillus Reuteri affect Spirometry Parameters in Cystic Fibrosis patients?

Seyedeh Zalfa Modarresi

Replay

Abstract

Slides

Beta-adrenergic sweat test in challenging cystic fibrosis diagnosis.

Mairead Kelly-aubert

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}